Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,920 | 7 | 68.7% |
| Travel and Lodging | $10,092 | 3 | 27.8% |
| Food and Beverage | $1,250 | 18 | 3.4% |
| Education | $25.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $13,785 | 4 | $0 (2019) |
| Medexus Pharma, Inc. | $11,598 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,940 | 1 | $0 (2020) |
| Gamida Cell Inc. | $3,609 | 5 | $0 (2024) |
| National Marrow Donor Program | $498.40 | 2 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $473.57 | 5 | $0 (2024) |
| Seagen Inc. | $141.26 | 1 | $0 (2022) |
| Legend Biotech USA Inc. | $106.24 | 2 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $66.29 | 1 | $0 (2022) |
| Amgen Inc. | $43.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,087 | 11 | Medexus Pharma, Inc. ($8,198) |
| 2023 | $244.68 | 4 | JAZZ PHARMACEUTICALS INC. ($125.00) |
| 2022 | $4,144 | 6 | Medexus Pharma, Inc. ($3,400) |
| 2021 | $17.25 | 1 | JAZZ PHARMACEUTICALS INC. ($17.25) |
| 2020 | $5,940 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($5,940) |
| 2019 | $13,785 | 4 | Chugai Pharmaceutical Co., Ltd. ($13,785) |
| 2018 | $68.28 | 2 | Amgen Inc. ($43.28) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Gamida Cell Inc. | OMISIRGE (Biological) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $143.43 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/30/2024 | Medexus Pharma, Inc. | — | Food and Beverage | In-kind items and services | $49.65 | General |
| 09/30/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,080.00 | General |
| 09/23/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/09/2024 | Gamida Cell Inc. | OMISIRGE (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 05/19/2024 | Medexus Pharma, Inc. | — | Food and Beverage | In-kind items and services | $28.14 | General |
| 05/10/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/22/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $46.38 | General |
| 01/11/2024 | Gamida Cell Inc. | OMISIRGE (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/18/2023 | Gamida Cell Inc. | OMISIRGE (Biological) | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2023 | Gamida Cell Inc. | OMISIRGE (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2023 | Legend Biotech USA Inc. | CARVYKTI (Biological) | Food and Beverage | In-kind items and services | $59.86 | General |
| Category: Oncology | ||||||
| 12/12/2022 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $141.26 | General |
| 09/14/2022 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 09/08/2022 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $294.12 | General |
| 09/08/2022 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $204.28 | General |
| 06/23/2022 | Siemens Medical Solutions USA, Inc. | ProBeam Proton Therapy System (Device) | Food and Beverage | In-kind items and services | $66.29 | General |
| Category: Oncology | ||||||
| 04/24/2022 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2021 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug), DEFITELIO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $5,940.00 | General |
| 11/13/2019 | Chugai Pharmaceutical Co., Ltd. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $9,274.86 | General |
| Category: None | ||||||
| 11/13/2019 | Chugai Pharmaceutical Co., Ltd. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,960.00 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 46 | 66 | $22,058 | $5,395 |
| 2021 | 3 | 40 | 70 | $17,744 | $4,361 |
| 2020 | 3 | 41 | 116 | $34,581 | $9,656 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $8,568 | $2,134 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 32 | $7,424 | $1,833 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 17 | $6,066 | $1,428 | 23.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 36 | $8,352 | $1,987 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 14 | $7,056 | $1,782 | 25.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 20 | $2,336 | $592.42 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 74 | $16,694 | $6,642 | 39.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 20 | $10,054 | $1,785 | 17.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 22 | $7,832 | $1,229 | 15.7% |
About Dr. Filippo Milano, M.D
Dr. Filippo Milano, M.D is a Hematology & Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1083842215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Filippo Milano, M.D has received a total of $36,286 in payments from pharmaceutical and medical device companies, with $12,087 received in 2024. These payments were reported across 29 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($24,920).
As a Medicare-enrolled provider, Milano has provided services to 127 Medicare beneficiaries, totaling 252 services with total Medicare billing of $19,412. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Seattle, WA
- Active Since 06/25/2009
- Last Updated 12/03/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083842215
Products in Payments
- Non-Covered Product (Drug) $13,785
- OMISIRGE (Biological) $3,609
- RYLAZE (Drug) $268.43
- DEFITELIO (Drug) $149.99
- ProBeam Proton Therapy System (Device) $66.29
- CARVYKTI (Biological) $59.86
- VYXEOS (Drug) $55.15
- Nplate (Biological) $43.28
- Marqibo (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Seattle
Mr. John Pesando, Md, MD
Hematology & Oncology — Payments: $12.8M
John Pagel, Md Phd, MD PHD
Hematology & Oncology — Payments: $1.3M
Dr. Langdon Miller, Md, MD
Hematology & Oncology — Payments: $674,815
Dr. Vijayakrishna Gadi, M.d. Phd, M.D. PHD
Hematology & Oncology — Payments: $534,649
Barbara Konkle, Md, MD
Hematology & Oncology — Payments: $331,390
Dr. Jill Johnsen, Md, MD
Hematology & Oncology — Payments: $291,732